Content about VIEW

May 21, 2013
iHealth Lab adds new products and partners to mobile personal healthcare offering

iHealth Lab Inc., today announced the release of two new fitness products to its existing lineup of wireless blood-pressure monitors and scales: the Wireless Pulse Oximeter and the Wireless Activity and Sleep Tracker. The company also announced new partnerships with two health and fitness communities, MyFitnessPal and RunKeeper.

April 17, 2013
Changes to REMS to allow dispensing of Vivus obesity drug in retail

The Food and Drug Administration has approved a modification to a program added to the labeling of an obesity drug to ensure patient safety.

March 22, 2013
Study finds improvements in cardiovascular health among South Asians who receive culturally relevant coaching

Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.

February 5, 2013
Budweiser Super Bowl ad most effective, consumer study finds

Budweiser's "Clydesdale" ad during the Super Bowl was the most effective aired during the football game, according to a new study.

February 1, 2013
Patients taking obesity drug experience improvement in cardiovascular risk factors, study finds

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

November 6, 2012
iHealth Labs launches latest round of Apple-compatible diagnostic devices

iHealth Labs on Tuesday announced that its latest suite of products will be available for purchase at major retailers and online later this month. The iHealth wireless blood pressure wrist monitor, wireless blood pressure monitor and wireless body analysis scale are already available at Best Buy and iHealthlabs.com, the company added.

September 19, 2012
Vivus launches obesity drug

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

June 22, 2012
Alexza resubmits Adasuve for regulatory review

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

February 23, 2012
Coupons.com names e-commerce aficionado Dawn Lepore to board

Coupons.com on Thursday announced the appointment of Dawn Lepore, former chairman and CEO of Drugstore.com, to its board of directors.

February 23, 2012
FDA committee recommends approval for obesity drug

A panel of experts at the Food and Drug Administration has recommended approval for an obesity drug that so far had not met much success at the agency.

December 14, 2011
FDA advisory committee recommends approval for schizophrenia, bipolar disorder drug

A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

December 7, 2011
Data from Qnexa study presented at World Diabetes Congress

Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

November 17, 2011
Need for more convenient therapies, competition from generics, biosimilars spurs RA drug development

The increase in the number of people with rheumatoid arthritis, and the challenges posed to drug makers by generics, is encouraging the development of new drugs for the disease, according to a new report by Frost & Sullivan.

October 17, 2011
Vivus resubmits application for Qnexa

Vivus has reapplied to the Food and Drug Administration for approval of a drug to treat obesity, the company said Monday.

October 4, 2011
Study: Asthma, COPD markets to see revenue growth, innovation

Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.

September 7, 2011
FDA accepts new drug application from Vivus

The Food and Drug Administration has accepted a regulatory approval application for a drug made by Vivus for treating erectile dysfunction.

June 8, 2011
Edison's EPI-743 granted orphan drug designation

The Food and Drug Administration has granted orphan drug designation to an investigational treatment made by Edison Pharmaceuticals for rare diseases, Edison said Wednesday.

February 23, 2011
Advanced BloodStop now available at CVS/pharmacy

LifeScience Plus recently introduced Advanced BloodStop, a bandage that helps stop bleeding in less than one minute, at CVS/pharmacy.

January 24, 2011
In study, Alexza's schizophrenia treatment significantly improves symptoms

An investigational schizophrenia drug appears effective in reducing agitation in patients with the disease, according to results of a late-stage clinical trial published in the British Journal of Psychiatry.

October 28, 2010
FDA declines to approve Qnexa

Vivus found itself foiled in its efforts to market a drug for obesity as the...

October 13, 2010
Coupons.com develops website for Grocery iQ app

Coupons.com's popular shopping-list mobile app is getting its own companion website....

© 2013 Drug Store News. All Rights Reserved.